| Literature DB >> 35300090 |
Tian-Yu Zhu1, Xiu-Tao Wu1, Chen Chen1, Xiao-Qin Liu1, Li Zhu1, Jian-Guang Luo1, Ling-Yi Kong1.
Abstract
Harringtonolide (HO, 1) is a bioactive diterpenoid tropone isolated from Cephalotaxus harringtonia with antiproliferation activity. Until now there have been no reports to elucidate its anticancer mechanism. Herein we report the synthesis of HO-derived probes (10, 11, and 12) to identify the possible target of HO. As a result, the application of a novel photoaffinity alkyne-tagged probe from HO (compound 12) showed direct engagement between HO and receptor for activated C kinase 1 (RACK1). Furthermore, HO could suppress the epithelial-mesenchymal transition (EMT) process and inhibit activation of the FAK/Src/STAT3 signaling pathway in A375 cells. This study provides a groundwork for HO as an effective antitumor agent that targets RACK1 to suppress cancer cell migration.Entities:
Year: 2022 PMID: 35300090 PMCID: PMC8919390 DOI: 10.1021/acsmedchemlett.1c00625
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345